Israel, Saudi Arabia to launch dementia research center
Saudi Arabia and Israel will begin an effort to find cures for dementia in the coming years, as the country seeks to develop the technology to treat the disease, a senior Israeli official said on Tuesday.
The official said that Israeli scientists have begun a pilot project to find the genetic markers that will enable the Alzheimer’s Disease Research Institute in Israel to work with a Saudi Arabian company to develop a diagnostic test.
The pilot project will involve a team of 30 researchers from the two countries, and the goal is to eventually start a new center, he said.
The Saudi firm is part of a consortium of 11 countries that are looking to develop Alzheimer’s treatments in an effort, in part, to counter the impact of the global pandemic.
The initiative is one of a number of initiatives to accelerate the development of a diagnostic system to test for Alzheimer’s, which is often misdiagnosed by doctors.
It is not clear whether the Saudi firm will also be involved in the new Alzheimer’s Research Institute, or whether it will be an independent entity.
The Saudi-Israeli partnership, if it succeeds, could potentially lead to a rapid shift in the field, which has struggled to find a cure for the disease.
Israeli doctors have been using blood tests to diagnose Alzheimer’s since the 1980s.
However, they have not found a specific marker for the disorder, or any genetic markers for the condition.